Influence of Sensory Stimulation on Sensory Parameters and Motor Function in Children With Developmental Coordination Disorder
Launched by THE JERZY KUKUCZKA ACADEMY OF PHYSICAL EDUCATION IN KATOWICE · May 5, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special type of therapy called intensive sensory stimulation can help improve motor skills and sensory functions in children aged 12 to 16 who have severe symptoms of Developmental Coordination Disorder (DCD). DCD makes it hard for children to coordinate their movements, and this study aims to find out if the new therapy is more effective than the standard therapy they usually receive. Researchers will compare two groups of children: one group will receive the intensive therapy, and the other will continue with standard therapy, to see which group shows better improvements in their ability to move their arms and sense things like pressure and temperature.
To join the study, children must be between 12 and 16 years old, have a diagnosis of severe DCD as measured by a specific assessment, and have typical intellectual development, meaning they are in mainstream schools. They also need to have permission from their parents or guardians. However, children with serious bone or nerve issues, recent surgeries, or ongoing pain won't be eligible to participate. This trial has not started recruiting participants yet, but it offers a chance for children with DCD to potentially benefit from a new therapy designed to enhance their daily functioning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • between 12-16 years of age
- • diagnosed severe symptoms of the developmental coordination disorder based on The Movement Assessment Battery for Children 2nd Edition (M-ABC 2), with scores ranging from 40 to 50
- • typical intellectual development (i.e., children attending mainstream education)
- • voluntary participation and informed consent signed by parents or legal guardians
- Exclusion Criteria:
- • current or previous diagnosis of serious orthopaedic or neurological conditions (e.g. fractures, congenital deformities, cerebral palsy, etc.)
- • history of any surgical procedures
- • history of significant musculoskeletal pain or dysfunction lasting more than two weeks and requiring medical or physiotherapeutic intervention, or any such symptoms occurring within one month prior to the study
- • any current musculoskeletal dysfunction and/or pain
- • body mass index exceeding 22 kg/m³
About The Jerzy Kukuczka Academy Of Physical Education In Katowice
The Jerzy Kukuczka Academy of Physical Education in Katowice is a distinguished institution dedicated to advancing the fields of physical education, sports science, and health promotion. Renowned for its commitment to research and innovation, the Academy fosters a collaborative environment that integrates academic excellence with practical application. Through its clinical trials, the Academy aims to contribute valuable insights into physical performance, rehabilitation, and wellness, ultimately enhancing the quality of life for individuals and communities. With a focus on evidence-based practices, the Academy is at the forefront of promoting a deeper understanding of the critical role of physical activity in health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Katowice, , Poland
Daugavpils, , Latvia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported